47 completed, 3 terminated, 2 recruiting, 1 unknown. 18 Phase 1, 12 Phase 4, 10 Phase 3, 5 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 18 | Completed 17, Terminated 1 |
| Phase 4 | 12 | Completed 11, Unknown 1 |
| Phase 3 | 10 | Completed 9, Terminated 1 |
| Phase 2 | 5 | Terminated 3, Completed 2 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Handok Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers HD-P023, Teneligliptin and Empagliflozin - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 40 | 2025-09-10 | 2026-02-05 |
| ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer Blood Sampling for ctDNA Analysis - Biliary Tract Cancer | Recruiting | CHA University | 100 | 2025-09-01 | 2026-03-18 | |
| Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission Contrave ER, Low-calorie meal box - Diabetes, Type 2, Obesity &Amp; Overweight | Phase 4 | Completed | Yeouido St. Mary's Hospital | 25 | 2025-07-01 | 2026-08-07 |
| Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers HD-P023, Teneligliptin, Empagliflozin High - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 40 | 2025-03-26 | 2025-07-31 |
| A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) Dual-combination therapy, Triple-combination therapy, Dexcom G7, Pasta - Type 2 Diabetes | Not applicable | Recruiting | Kyu Chang Won | 5950 | 2024-11-21 | 2025-04-24 |
| Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers HD-P023, Teneligliptin, Empagliflozin - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 40 | 2024-05-10 | 2025-02-04 |
| Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers Irbesartan High/Amlodipine FDC, Irbesartan High, Amlodipine - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 44 | 2022-10-18 | 2023-08-18 |
| Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet, Teneligliptin Placebo Oral Tablet - Type 2 Diabetes | Phase 3 | Completed | Handok Inc. | 214 | 2022-10-12 | 2025-01-27 |
| A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South Korea aHUS | Completed | Handok Inc. | 97 | 2022-10-04 | 2025-01-27 | |
| Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet, Teneligliptin Placebo Oral Tablet - Type 2 Diabetes | Phase 3 | Completed | Handok Inc. | 235 | 2022-09-27 | 2025-01-24 |
| Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers Irbesartan/Amlodipine High FDC, Irbesartan, Amlodipine High - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 44 | 2022-09-23 | 2023-08-18 |
| Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers Irbesartan/Amlodipine FDC, Irbesartan, Amlodipine - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 46 | 2022-09-13 | 2023-08-18 |
| Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients Irbesartan/Amlodipine, Irbesartan - Essential Hypertension | Phase 3 | Completed | Handok Inc. | 157 | 2022-07-14 | 2023-08-18 |
| Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients Irbesartan/Amlodipine low, Irbesartan/Amlodipine high, Irbesartan - Essential Hypertension | Phase 3 | Completed | Handok Inc. | 271 | 2022-07-05 | 2023-08-18 |
| A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH Patients PNH | Completed | Handok Inc. | 80 | 2020-12-11 | 2025-01-28 | |
| Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin Teneligliptin, Empagliflozin, Teneligliptin and Empagliflozin - Type 2 Diabetes Mellitus | Phase 1 | Completed | Handok Inc. | 32 | 2020-09-15 | 2021-11-15 |
| A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients CTX-009 (ABL001), Paclitaxel, Irinotecan - P1b: Advanced Solid Tumors, P2: Biliary Tract Cancer | Phase 1 / Phase 2 | Terminated | Handok Inc. | 41 | 2020-06-22 | 2025-01-27 |
| Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension Irbesartan/Amlodipine - Essential Hypertension | Phase 2 | Completed | Handok Inc. | 440 | 2020-05-21 | 2022-06-30 |
| A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac Ketoprofen topical, Diclofenac Topical - Osteoarthritis | Phase 3 | Completed | Handok Inc. | 236 | 2020-03-20 | 2021-01-20 |
| A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies NOV1601(CHC2014) - Phase 1, Solid Tumor, Adult | Phase 1 | Completed | Handok Inc. | 17 | 2019-08-09 | 2021-09-16 |
Showing 20 of 53. Sign in to see all of them.
Diabetes Mellitus, Type 2 (16) · Diabetes Mellitus (3) · Essential Hypertension (3) · Cryopyrin-Associated Periodic Syndromes (2) · Hypertension (2) · Urinary Bladder Neoplasms (2) · Arthritis, Rheumatoid (1) · Asthma (1) · Biliary Tract Neoplasms (1) · Gastrointestinal Neoplasms (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Obesity (1) · Osteoarthritis (1) · Overweight (1) · Prostatic Hyperplasia (1)
3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine (12) · Metformin (6) · glimepiride (6) · Irbesartan (5) · Amlodipine (4) · empagliflozin (3) · Irinotecan (2) · Tablets (2) · alfuzosin (2) · Amisulpride (1) · Atorvastatin (1) · BID protein, human (1) · Blood Specimen Collection (1) · Curcumin (1) · Diclofenac (1)
South Korea (48) · Japan (1) · Russia (1)
In-Jin Jang, Professor (2) · Chang Hwan Yoon, MD (1) · Dae Young Zang, MD, PhD (1) · Dong-Ju Choi, MD (1) · Dong-Wan Kim, MD, PhD (1) · Hong Jae Chon (1) · Hyeong Ki Lee, Professor (1) · Hyewon Chung (1) · Hyou-Young Rhim (1) · Hyou-Young Rhim, Dr. (1) · Hyou-Young Rhim, MD (1) · Hyuk-Sang Kwon, MD, PhD (1) · JH Kim (1)
PMID 38704294, PMID 22036245, PMID 25422771, PMID 31079357, PMID 34130378, PMID 42832816